A Clinton Twist On Price Negotiation: Hillary’s Role With PEPFAR
Executive Summary
Former President Bill Clinton's convention speech cites his wife's experience with driving down cost of HIV therapy supported by the AIDS relief program.
You may also be interested in...
Clinton Vs. Trump: Three Scenarios For Biopharma
The presidential campaign is about to begin in earnest, and for biopharma companies, the biggest question is what the outcome will mean for the pricing climate in the US. It isn’t an easy question to answer.
The Next COVID Vaccine Race: Comparative Efficacy In Post-Market
Multiple simultaneous sponsors, foreshortened regulatory reviews, and a packet of unanswered post-approval efficacy issues make for what should be very competitive – and inherently comparative – post-market assessment period for the upcoming SARS-CoV-2 vaccines.
COVID-19 Clinical Trial Disruptions: A Real-World Test Of De-Centralized Techniques
US FDA asks oncology drug sponsors for information on the impact of modifications to clinical trials during the pandemic – with close attention to remote monitoring and data collection.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: